FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

31009011000001107: Zevtera 500mg powder for concentrate for solution for infusion vials (Basilea Pharmaceutica International Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 09-Dec 2015. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
95779201000001119 Zevtera 500mg powder for concentrate for solution for infusion vials (Basilea Pharmaceutica International Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
109981801000001113 Zevtera 500mg powder for concentrate for solution for infusion vials (Correvio UK Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Zevtera 500mg powder for concentrate for solution for infusion vials (Basilea Pharmaceutica International Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Zevtera 500mg powder for concentrate for solution for infusion vials (Basilea Pharmaceutica International Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction hospital only true Inferred relationship Existential restriction modifier
Zevtera 500mg powder for concentrate for solution for infusion vials (Basilea Pharmaceutica International Ltd) Is a Ceftobiprole 500mg powder for solution for infusion vials true Inferred relationship Existential restriction modifier
Zevtera 500mg powder for concentrate for solution for infusion vials (Basilea Pharmaceutica International Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Zevtera 500mg powder for concentrate for solution for infusion vials (Basilea Pharmaceutica International Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Zevtera 500mg powder for concentrate for solution for infusion vials (Basilea Pharmaceutica International Ltd) Has specific active ingredient Ceftobiprole medocaril sodium true Inferred relationship Existential restriction modifier
Zevtera 500mg powder for concentrate for solution for infusion vials (Basilea Pharmaceutica International Ltd) Has dispensed dose form Powder for infusion solution false Inferred relationship Existential restriction modifier
Zevtera 500mg powder for concentrate for solution for infusion vials (Basilea Pharmaceutica International Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Ceftobiprole false Inferred relationship Existential restriction modifier
Zevtera 500mg powder for concentrate for solution for infusion vials (Basilea Pharmaceutica International Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Zevtera 500mg powder for concentrate for solution for infusion vials (Basilea Pharmaceutica International Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Zevtera 500mg powder for concentrate for solution for infusion vials (Basilea Pharmaceutica International Ltd) Is a Zevtera true Inferred relationship Existential restriction modifier
Zevtera 500mg powder for concentrate for solution for infusion vials (Basilea Pharmaceutica International Ltd) Has active ingredient Substance with cephalosporin structure and antibacterial mechanism of action false Inferred relationship Existential restriction modifier
Zevtera 500mg powder for concentrate for solution for infusion vials (Basilea Pharmaceutica International Ltd) Has manufactured dose form Powder for infusion solution false Inferred relationship Existential restriction modifier
Zevtera 500mg powder for concentrate for solution for infusion vials (Basilea Pharmaceutica International Ltd) Has basis of strength substance Ceftobiprole false Inferred relationship Existential restriction modifier
Zevtera 500mg powder for concentrate for solution for infusion vials (Basilea Pharmaceutica International Ltd) Has basis of strength substance Ceftobiprole true Inferred relationship Existential restriction modifier
Zevtera 500mg powder for concentrate for solution for infusion vials (Basilea Pharmaceutica International Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Ceftobiprole true Inferred relationship Existential restriction modifier
Zevtera 500mg powder for concentrate for solution for infusion vials (Basilea Pharmaceutica International Ltd) Has dispensed dose form Powder for conventional release solution for infusion true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Zevtera 500mg powder for concentrate for solution for infusion vials (Basilea Pharmaceutica International Ltd) 10 vial Has AMP True Zevtera 500mg powder for concentrate for solution for infusion vials (Basilea Pharmaceutica International Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start